Cadherin-11 Antibody (667039) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB17901H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
HRP
Antibody Source
Monoclonal Mouse IgG2A Clone # 667039
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Cadherin-11
Phe23-Thr617
Accession # AAA35622
Phe23-Thr617
Accession # AAA35622
Specificity
Detects human Cadherin-11 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) Cadherin-4, -6, -8, -12, -13,-17, rhE-Cadherin, rhN-Cadherin, rhP-Cadherin, or rhVE-Cadherin is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for Cadherin-11 Antibody (667039) [HRP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cadherin-11
Alternate Names
Cadherin11, CDH11, CDHOB, OB-Cadherin
Gene Symbol
CDH11
Additional Cadherin-11 Products
Product Documents for Cadherin-11 Antibody (667039) [HRP]
Product Specific Notices for Cadherin-11 Antibody (667039) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...